Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHA: 600196)
China flag China · Delayed Price · Currency is CNY
27.40
+0.55 (2.05%)
Nov 20, 2024, 11:30 AM CST

Shanghai Fosun Pharmaceutical (Group) Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Operating Revenue
41,12340,91143,37738,66629,91028,351
Upgrade
Other Revenue
488.71488.71574.48345.58396.96234.4
Upgrade
Revenue
41,61141,40043,95239,01130,30728,585
Upgrade
Revenue Growth (YoY)
-3.29%-5.81%12.66%28.72%6.02%14.72%
Upgrade
Cost of Revenue
21,82721,71723,25620,29413,79811,556
Upgrade
Gross Profit
19,78519,68320,69618,71716,50917,029
Upgrade
Selling, General & Admin
13,42814,08712,99912,32811,12412,438
Upgrade
Research & Development
3,8394,3464,3023,8372,7952,041
Upgrade
Other Operating Expenses
35.77-44.99-88.15-57.86-108.2484.64
Upgrade
Operating Expenses
17,38618,49917,27516,18013,89114,650
Upgrade
Operating Income
2,3981,1843,4202,5372,6182,380
Upgrade
Interest Expense
-1,445-1,325-963.81-822.54-880.95-1,075
Upgrade
Interest & Investment Income
3,1963,8664,6604,8582,4843,752
Upgrade
Currency Exchange Gain (Loss)
13.0313.0362.36154.63-24.7940.76
Upgrade
Other Non Operating Income (Expenses)
-0.36-57.73-31.78-31.06-81.16-50.7
Upgrade
EBT Excluding Unusual Items
4,1623,6807,1476,6954,1155,047
Upgrade
Impairment of Goodwill
---180-150--75
Upgrade
Gain (Loss) on Sale of Investments
-1,401-488.66-2,498-110.19494.8-650.79
Upgrade
Gain (Loss) on Sale of Assets
1.785.56125.6-15.425.7117.73
Upgrade
Asset Writedown
207.81-42.14-20.48-171.01-10.11-14.98
Upgrade
Other Unusual Items
73.36109.380.25-206.1672.71201.59
Upgrade
Pretax Income
3,0443,2654,5746,0434,6784,526
Upgrade
Income Tax Expense
283.91369.5626.921,066737.86782.23
Upgrade
Earnings From Continuing Operations
2,7602,8953,9474,9763,9403,744
Upgrade
Minority Interest in Earnings
-645.93-508.8-216.66-247.56-277.17-421.9
Upgrade
Net Income
2,1142,3863,7314,7293,6633,322
Upgrade
Net Income to Common
2,1142,3863,7314,7293,6633,322
Upgrade
Net Income Growth
-40.92%-36.04%-21.10%29.10%10.27%22.66%
Upgrade
Shares Outstanding (Basic)
2,6892,6702,6072,5632,5632,563
Upgrade
Shares Outstanding (Diluted)
2,6892,6702,6072,5632,5632,563
Upgrade
Shares Change (YoY)
0.42%2.40%1.74%--1.57%
Upgrade
EPS (Basic)
0.790.891.431.851.431.30
Upgrade
EPS (Diluted)
0.780.891.431.851.431.30
Upgrade
EPS Growth
-41.40%-37.76%-22.50%29.10%10.27%21.13%
Upgrade
Free Cash Flow
-206.94-1,922-1,671-1,035-1,857-739.65
Upgrade
Free Cash Flow Per Share
-0.08-0.72-0.64-0.40-0.72-0.29
Upgrade
Dividend Per Share
0.2700.2700.4200.5600.4300.390
Upgrade
Dividend Growth
-35.71%-35.71%-25.00%30.23%10.26%21.88%
Upgrade
Gross Margin
47.55%47.54%47.09%47.98%54.47%59.57%
Upgrade
Operating Margin
5.76%2.86%7.78%6.50%8.64%8.32%
Upgrade
Profit Margin
5.08%5.76%8.49%12.12%12.09%11.62%
Upgrade
Free Cash Flow Margin
-0.50%-4.64%-3.80%-2.65%-6.13%-2.59%
Upgrade
EBITDA
5,4513,8385,5414,1844,0833,676
Upgrade
EBITDA Margin
13.10%9.27%12.61%10.72%13.47%12.86%
Upgrade
D&A For EBITDA
3,0522,6532,1211,6471,4651,296
Upgrade
EBIT
2,3981,1843,4202,5372,6182,380
Upgrade
EBIT Margin
5.76%2.86%7.78%6.50%8.64%8.32%
Upgrade
Effective Tax Rate
9.33%11.32%13.70%17.65%15.77%17.28%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.